Abstract
Cephradine, a new semisynthetic cephalosporin derivative, is 7[d(−)-2-amino-2-(1,4-cyclohexadien-1-yl) acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate. The compound has a broad spectrum of antimicrobial activity in vitro. When given subcutaneously to mice, cephradine was appreciably more effective than cephalothin against infections induced by penicillinase-producing Staphylococcus, Escherichia coli, Klebsiella pneumoniae, or Enterobacter cloacae strains. Cephradine and cephaloridine possessed equivalent activity in treating infections caused by these same three gram-negative bacteria. The mean total bioactivity of cephradine in the serum of mice peaked within 30 min (59 μg/ml) after parenteral administration and was approximately threefold that of cephalothin (20 μg/ml), but less than that of cephaloridine (83 μg/ml). Nearly all of the administered cephradine (84%) and cephaloridine (70%) were excreted in the urine as the parent compounds. In contrast, only 47% (total bioactivity) of administered cephalothin was recovered, an amount that represented only 15 to 20% of the parent substance.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dolfini J. E., Applegate H. E., Bach G., Basch H., Bernstein J., Schwartz J., Weisenborn F. L. A new class of semisynthetic penicillins and cephalosporins derived from D-2-(1,4-cyclohexadienyl)glycine. J Med Chem. 1971 Feb;14(2):117–119. doi: 10.1021/jm00284a008. [DOI] [PubMed] [Google Scholar]
- Eykyn S. Use and control of cephalosporins. J Clin Pathol. 1971 Jul;24(5):419–429. doi: 10.1136/jcp.24.5.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gadebusch H., Miraglia G., Pansy F., Renz K. Epicillin: experimental chemotherapy, pharmacodynamics, and susceptibility testing. Infect Immun. 1971 Jul;4(1):50–53. doi: 10.1128/iai.4.1.50-53.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landa L. Cephradine in the treatment of intestinal infections caused by Shigella or Salmonella organisms. Curr Ther Res Clin Exp. 1972 Aug;14(8):496–502. [PubMed] [Google Scholar]
- Miller A. K., Frost B. M., Valiant M. E., Kropp H., Hendlin D. Phosphonomycin. V. Evaluation in mice. Antimicrob Agents Chemother (Bethesda) 1969;9:310–315. [PubMed] [Google Scholar]